US pharmaceutical giant Johnson & Johnson has started human trials on a possible vaccine against Ebola. The company is hoping to move on to studies on large groups of patients by April.
The Oxford Vaccine Group at Britain's Oxford University is carrying out Phase I testing of the Ebola vaccine. 72 healthy volunteers are part of the test that will examine how their bodies tolerate the potential vaccine.
Ebola Virus Disease
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.
Advertisement
Johnson & Johnson said, "At the end of October we would spend up to $200 million to speed up and expand our Ebola vaccine program. We have already produced more than 400,000 doses, and two million courses will be ready by the year end. If necessary we can make five million doses within 12 to 18 months."
Source: Medindia
British Ebola Nurse Critical but in Stable Condition
A British nurse, Pauline Cafferkey, who is being treated for Ebola at London's Royal Free hospital, is in a critical but stable condition, reported Britain's health minister.
Advertisement
 Government of Somalia Dismisses Rumors of Ebola OutbreakThe government of Somalia has reassured its' residents that there was no outbreak of Ebola in the country. | Advertisement
|
Ebola Outbreak Will End in 2015
Anthony Banbury, the outgoing head of the United Nations Ebola Emergency Response (UNMEER) has said that the disease will be ended in 2015.
Advertisement
Recommended Reading
Latest Clinical Trials News
Is there a new way to treat lymphedema? Yes, swelling due to damaged lymphatic vessels can be treated using nanoparticles that can travel through the lymphatic vessels.
Early and late Chronic Traumatic Encephalopathy (CTE) disease processes in the post-mortem brains were similar in some ways but dramatically different in others.
Researchers have developed a new hydrogel biomaterial that adheres to heart tissue to prevent scar tissue formation after a heart attack and its consequences.
The oil extracted from Cannabidiol (CBD) present in cannabis (marijuana) does not lower pain scores after common treatment for urinary stones.
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it prompted immune response and was safe.